Keaveny AP - Search Results

1

Small intestinal bacterial overgrowth and nonalcoholic fatty liver disease: a systematic review and meta-analysis.

Wijarnpreecha K, Lou S, Watthanasuntorn K, Kroner PT, Cheungpasitporn W, Lukens FJ, Pungpapong S, Keaveny AP, Ungprasert P. Wijarnpreecha K, et al. Among authors: keaveny ap. Eur J Gastroenterol Hepatol. 2020 May;32(5):601-608. doi: 10.1097/MEG.0000000000001541. Eur J Gastroenterol Hepatol. 2020. PMID: 31567712

2

[No title available]

[No authors listed] [No authors listed] PMID: 37160014

3

Clinicopathologic findings and outcomes of liver transplantation using grafts from donors with unrecognized and unusual diseases.

Pungpapong S, Krishna M, Abraham SC, Keaveny AP, Dickson RC, Nakhleh RE. Pungpapong S, et al. Among authors: keaveny ap. Liver Transpl. 2006 Feb;12(2):310-5. doi: 10.1002/lt.20641. Liver Transpl. 2006. PMID: 16447189 Free article.

4

Peritonitis after liver transplantation: Incidence, risk factors, microbiology profiles, and outcome.

Pungpapong S, Alvarez S, Hellinger WC, Kramer DJ, Willingham DL, Mendez JC, Nguyen JH, Hewitt WR, Aranda-Michel J, Harnois DM, Rosser BG, Hughes CB, Grewal HP, Satyanarayana R, Dickson RC, Steers JL, Keaveny AP. Pungpapong S, et al. Among authors: keaveny ap. Liver Transpl. 2006 Aug;12(8):1244-52. doi: 10.1002/lt.20801. Liver Transpl. 2006. PMID: 16741932 Free article.

5

Hepatobiliary sarcoidosis mimicking Klatskin's cholangiocarcinoma.

Pungpapong S, Steers JL, Wallace MB, Krishna M, Keaveny AP. Pungpapong S, et al. Among authors: keaveny ap. Gastrointest Endosc. 2006 Jul;64(1):124-5. doi: 10.1016/j.gie.2006.01.033. Gastrointest Endosc. 2006. PMID: 16813819 No abstract available.

6

Accuracy and interobserver agreement of small-caliber vs. conventional esophagogastroduodenoscopy for evaluating esophageal varices.

Pungpapong S, Keaveny A, Raimondo M, Dickson R, Woodward T, Harnois D, Wallace M. Pungpapong S, et al. Endoscopy. 2007 Aug;39(8):673-80. doi: 10.1055/s-2007-966351. Epub 2007 Jun 22. Endoscopy. 2007. PMID: 17583856

7

Serum fibrosis markers can predict rapid fibrosis progression after liver transplantation for hepatitis C.

Pungpapong S, Nunes DP, Krishna M, Nakhleh R, Chambers K, Ghabril M, Dickson RC, Hughes CB, Steers J, Nguyen JH, Keaveny AP. Pungpapong S, et al. Among authors: keaveny ap. Liver Transpl. 2008 Sep;14(9):1294-302. doi: 10.1002/lt.21508. Liver Transpl. 2008. PMID: 18756457 Free article.

8

Use of liver grafts from donation after cardiac death donors for recipients with hepatitis C virus.

Taner CB, Bulatao IG, Keaveny AP, Willingham DL, Pungpapong S, Perry DK, Rosser BG, Harnois DM, Aranda-Michel J, Nguyen JH. Taner CB, et al. Among authors: keaveny ap. Liver Transpl. 2011 Jun;17(6):641-9. doi: 10.1002/lt.22258. Liver Transpl. 2011. PMID: 21618684 Free article.

9

Events in procurement as risk factors for ischemic cholangiopathy in liver transplantation using donation after cardiac death donors.

Taner CB, Bulatao IG, Willingham DL, Perry DK, Sibulesky L, Pungpapong S, Aranda-Michel J, Keaveny AP, Kramer DJ, Nguyen JH. Taner CB, et al. Among authors: keaveny ap. Liver Transpl. 2012 Jan;18(1):100-11. doi: 10.1002/lt.22404. Liver Transpl. 2012. PMID: 21837741 Free article.

10

Multicenter experience using telaprevir or boceprevir with peginterferon and ribavirin to treat hepatitis C genotype 1 after liver transplantation.

Pungpapong S, Aqel BA, Koning L, Murphy JL, Henry TM, Ryland KL, Yataco ML, Satyanarayana R, Rosser BG, Vargas HE, Charlton MR, Keaveny AP. Pungpapong S, et al. Among authors: keaveny ap. Liver Transpl. 2013 Jul;19(7):690-700. doi: 10.1002/lt.23669. Epub 2013 Jun 3. Liver Transpl. 2013. PMID: 23696372 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

115 results

Search Page